Delivery Order SPE2DR25D3012-SPE2DR26F4D5L
Award Date 12/16/25
Potential Completion Date 12/17/25
Potential Value $10K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 16, 2025, for the supply of Vaxneuvance 0.5 mL syringes with a ceiling value of $5,605.77. This is a firm fixed price delivery order with an ultimate completion date of December 17, 2025, and represents a non-set-aside, competitively awarded contract. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for VAXNEUVANCE 0.5 ML syringes valued at $5,552.15 on May 28, 2025, with an ultimate completion date of May 29, 2025. This competitive, firm fixed-price delivery order represents a non-set-aside award for pneumococcal vaccine supply to support federal medical procurement needs. The contract's place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a $10,020.45 firm fixed price delivery order to AmerisourceBergen Drug Corp for 0.5 mL syringes of Vaxneuvance vaccine. The contract, which was not set-aside and competitively awarded, was executed on December 3, 2025, with an ultimate completion date of December 4, 2025. Performance will be conducted at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a routine pharmaceutical procurement supporting...
- The Defense Logistics Agency awarded a $7,803.36 delivery order to AmerisourceBergen Drug Corp on December 3, 2025, for the supply of Vaxneuvance 0.5 mL syringes. The contract is a firm fixed price delivery order with performance completion by December 4, 2025, and will be fulfilled at the contractor's Conshohocken, Pennsylvania location. This non-set-aside award reflects competitive procurement practices and represents a routine transaction under AmerisourceBergen's existing contract vehicles...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $25,224.41 to AmerisourceBergen Drug Corp for the supply of Vaxneuvance 0.5 mL syringes. This non-competitive, firm fixed-price delivery order was executed on November 24, 2025, with an ultimate completion date of November 25, 2025, and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. Vaxneuvance is a pneumococcal vaccine, indicating this delivery supports the federal medical supply...
- The Defense Logistics Agency awarded a $7,269.85 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Vaxneuvance 0.5 mL syringes on October 31, 2025, with an ultimate completion date of November 3, 2025. The contract, which is not set-aside, will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 5, 2025, for the supply of Vaxneuvance 0.5 mL syringes, with a contract ceiling value of $8,954.31. This is a firm fixed-price delivery order with an ultimate completion date of December 8, 2025. The award is not set-aside and was competitively awarded, demonstrating AmerisourceBergen's capability to fulfill federal pharmaceutical procurement requirements. The place of performance is located in...
- The Defense Logistics Agency awarded a $7,758.36 delivery order to AmerisourceBergen Drug Corp for the supply of Vaxneuvance 0.5 mL syringes on a firm fixed price basis. The contract, issued on December 8, 2025, with an ultimate completion date of December 9, 2025, represents a small-value transaction under AmerisourceBergen's larger indefinite delivery contract vehicle with DLA Troop Support Medical. This award carries no set-aside designation, indicating it was competitively awarded through...
- The Defense Logistics Agency awarded a $3,871.68 delivery order to AmerisourceBergen Drug Corp on December 15, 2025, for Vaxneuvance 0.5 ml syringes to be delivered to the contractor's facility in Conshohocken, Pennsylvania by December 16, 2025. This delivery order, issued under a firm fixed price contract with no set-aside designation, represents a competitively awarded transaction within AmerisourceBergen's broader relationship with the federal government's medical supply chain. This award...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $8,000.54 to AmerisourceBergen Drug Corp for the supply of Vaxneuvance 0.5 ML syringes on August 26, 2025, with an ultimate completion date of August 27, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Vaxneuvance is a pneumococcal vaccine product, reflecting the critical role AmerisourceBergen...